Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report
Background Coronavirus disease 2019 (COVID-19) is associated with diffuse lung damage.
Corticosteroids may modulate immune-mediated lung injury and reducing progression to …
Corticosteroids may modulate immune-mediated lung injury and reducing progression to …
[HTML][HTML] Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study
…, FR Machado, KK Reinhart, K Rowan… - The Lancet, 2020 - thelancet.com
Background Sepsis is life-threatening organ dysfunction due to a dysregulated host response
to infection. It is considered a major cause of health loss, but data for the global burden of …
to infection. It is considered a major cause of health loss, but data for the global burden of …
Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
…, AC Gordon, PR Mouncey, F Al-Beidh, KM Rowan… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
[HTML][HTML] Trial of early, goal-directed resuscitation for septic shock
…, M Singer, JD Young, KM Rowan - … England Journal of …, 2015 - Mass Medical Soc
Background Early, goal-directed therapy (EGDT) is recommended in international guidelines
for the resuscitation of patients presenting with early septic shock. However, adoption has …
for the resuscitation of patients presenting with early septic shock. However, adoption has …
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19)
is limited. Objective To determine whether hydrocortisone improves outcome for …
is limited. Objective To determine whether hydrocortisone improves outcome for …
[HTML][HTML] Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Background Lopinavir–ritonavir has been proposed as a treatment for COVID-19 on the basis
of in vitro activity, preclinical studies, and observational studies. Here, we report the results …
of in vitro activity, preclinical studies, and observational studies. Here, we report the results …
Effect of a perioperative, cardiac output–guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and …
…, A Ahern, K Griggs, R Scott, C Hinds, K Rowan… - Jama, 2014 - jamanetwork.com
Importance Small trials suggest that postoperative outcomes may be improved by the use of
cardiac output monitoring to guide administration of intravenous fluid and inotropic drugs as …
cardiac output monitoring to guide administration of intravenous fluid and inotropic drugs as …
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A (H1N1)
…, GD Perkins, D Menon, BL Taylor, KM Rowan - Jama, 2011 - jamanetwork.com
Context Extracorporeal membrane oxygenation (ECMO) can support gas exchange in
patients with severe acute respiratory distress syndrome (ARDS), but its role has remained …
patients with severe acute respiratory distress syndrome (ARDS), but its role has remained …
Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial
…, W Brampton, D Williams, D Young, K Rowan - The Lancet, 2005 - thelancet.com
Background Over the past 30 years the pulmonary artery catheter (PAC) has become a widely
used haemodynamic monitoring device in the management of critically ill patients, though …
used haemodynamic monitoring device in the management of critically ill patients, though …
